Literature DB >> 29308922

Uterine smooth muscle tumours with hyperintense area on T1 weighted images: differentiation between leiomyosarcomas and leiomyomas.

Tomohiro Ando1, Hiroki Kato1, Tatsuro Furui2, Ken-Ichirou Morishige2, Satoshi Goshima1, Masayuki Matsuo1.   

Abstract

OBJECTIVE: Hyperintense area on T1 weighted images (T1 HIA) have been reported as suggestive features of uterine leiomyosarcoma (LMS), but differentiating LMS from leiomyoma (LM) is often difficult. This study aimed to evaluate the differences between uterine LMS and LM demonstrating intratumoral T1 HIA.
METHODS: MRI was performed in 509 patients with 1137 uterine smooth muscle tumours [14 LMSs, 5 smooth muscle tumours of uncertain malignant potential , and 1118 LMs] which exceeded 3 cm in diameter. LM with red degeneration and lipoleiomyoma were excluded from the study. We retrospectively reviewed the images and assessed T1 HIA within tumours. Results T1 HIAs were observed in 11/14 (78.6%) LMSs, 0/5 (0%) smooth muscle tumours of uncertain malignant potential, and 15/1118 (1.3%) LMs. T1 HIAs were more homogenous (53 vs 0%, p < 0.01) and more well-demarcated (60 vs 9%, p < 0.05) in LMs than in LMSs. T2 hypointense rim within T1 HIA (53 vs 9%, p < 0.05) was more frequently observed in LMs than in LMSs. The occupying rate of T1 HIA (0.20 ± 0.24 vs 0.42 ± 0.27, p < 0.05) was smaller in LMs than in LMSs. The signal intensity ratio of T1 HIA (1.83 ± 0.36 vs 1.38 ± 0.23, p < 0.01) was greater in LMs than in LMSs.
CONCLUSION: T1 HIA within LM showed more homogeneity, better demarcation, smaller occupying rate, and higher signal intensity than T1 HIA within LMS. Advances in knowledge: The differences in T1 HIA within tumours may be useful for differentiating between LMS and LM.

Entities:  

Mesh:

Year:  2018        PMID: 29308922      PMCID: PMC5966007          DOI: 10.1259/bjr.20170767

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

Review 1.  Uterine sarcomas: clinical presentation and MRI features.

Authors:  Pedro Santos; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Jan-Feb       Impact factor: 2.630

Review 2.  MR imaging of atypical fibroids.

Authors:  Candice Bolan; Melanie P Caserta
Journal:  Abdom Radiol (NY)       Date:  2016-12

Review 3.  Review of Leiomyoma Variants.

Authors:  Elizabeth Kagan Arleo; Peter E Schwartz; Pei Hui; Shirley McCarthy
Journal:  AJR Am J Roentgenol       Date:  2015-10       Impact factor: 3.959

Review 4.  Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.

Authors:  Esther Oliva
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 5.  Myomas and pregnancy.

Authors:  J P Phelan
Journal:  Obstet Gynecol Clin North Am       Date:  1995-12       Impact factor: 2.844

6.  Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment.

Authors:  E Murase; E S Siegelman; E K Outwater; L A Perez-Jaffe; R W Tureck
Journal:  Radiographics       Date:  1999 Sep-Oct       Impact factor: 5.333

Review 7.  Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds.

Authors:  H Ueda; K Togashi; I Konishi; M L Kataoka; T Koyama; T Fujiwara; H Kobayashi; S Fujii; J Konishi
Journal:  Radiographics       Date:  1999-10       Impact factor: 5.333

8.  Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.

Authors:  S W Bell; R L Kempson; M R Hendrickson
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

9.  Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.

Authors:  A Goto; S Takeuchi; K Sugimura; T Maruo
Journal:  Int J Gynecol Cancer       Date:  2002 Jul-Aug       Impact factor: 3.437

10.  Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma.

Authors:  Diana Lim; Teresa Alvarez; Marisa R Nucci; Blake Gilks; Teri Longacre; Robert A Soslow; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

View more
  6 in total

Review 1.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 2.  Evidence-Based Management of Uterine Fibroids With Botanical Drugs-A Review.

Authors:  Masita Arip; Vi Lien Yap; Mogana Rajagopal; Malarvili Selvaraja; K Dharmendra; Sasikala Chinnapan
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

Review 3.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

Review 4.  Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis.

Authors:  Yenpo Lin; Ren-Chin Wu; Yen-Ling Huang; Kueian Chen; Shu-Chi Tseng; Chin-Jung Wang; Angel Chao; Chyong-Huey Lai; Gigin Lin
Journal:  Abdom Radiol (NY)       Date:  2022-03-26

5.  Diagnostic Performance of MRI to Differentiate Uterine Leiomyosarcoma from Benign Leiomyoma: A Meta-Analysis.

Authors:  Mayur Virarkar; Radwan Diab; Sarah Palmquist; Roland Bassett; Priya Bhosale
Journal:  J Belg Soc Radiol       Date:  2020-11-24       Impact factor: 1.894

Review 6.  Differentiating uterine sarcoma from leiomyoma: BET1T2ER Check!

Authors:  Janette Smith; Jeries Paolo Zawaideh; Hilal Sahin; Susan Freeman; Helen Bolton; Helen Clare Addley
Journal:  Br J Radiol       Date:  2021-05-05       Impact factor: 3.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.